"ABLE Human Motion was created almost 6 years ago with the vision of democratising robot... 24/10/2024 Healthcare Access to innovation Personalized medicine Financing Talento Corporate Partners - GENESIS Biomed
The public ecosystem of the Barcelona Science Park raises 70 million euros in 2023, 40% m... 24/10/2024 Healthcare Access to innovation Industrial biotechnology International Financing Talento These data consolidate the Barcelona Science Park as one of the most powerful hubs for public innovation in health in... Partners - Parc Científic de Barcelona
Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European ... 23/10/2024 Healthcare Access to innovation Innovative drugs Partners - THERIVA BIOLOGICS S.L.
La IA ayuda a los radiólogos a detectar más del 90% de cáncer de próstata en España 22/10/2024 Healthcare Access to innovation Spanish company Quibim's QP-Prostate solution, which uses biopsy and MRI data for training, achieves higher accuracy... Partners - Quibim SL
ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic ... 18/10/2024 Healthcare Innovative drugs ATX-01 is the industry’s first anti-microRNA therapeutic to be investigated in DM1 Partners - ARTHEx Biotech
ORYZON announces formal grant of key European patent for vafidemstat 14/10/2024 Healthcare Innovative drugs International EU projects For the treatment of aggression and social withdrawal. Partners - Oryzon Genomics
AEMPS approves Peaches' clinical trial with selective secretomes to treat COVID-19-associa... 10/10/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will help combat cytokine storm, a... Partners - PEACHES BIOTECH S.L.
"ApToll is an immune modulator to treat ischaemic stroke in the acute phase. We have suc... 10/10/2024 Healthcare Innovative drugs David Segarra, an aptamer technology entrepreneur, co-founded aptaTargets in 2014 and has led the company to bring... Partners - GENESIS Biomed
Fecundis secures $2.4 million in seed funding 08/10/2024 Healthcare Access to innovation Personalized medicine This funding will allow the company -based in the Barcelona Science Parkspeed up the path to market of their first... Partners - Parc Científic de Barcelona
AEMPS approves Peaches clinical trial with selective secretomes to treat COVID-19-associat... 08/10/2024 Healthcare Innovative drugs Personalized medicine Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will help combat cytokine storm, a... Partners - PEACHES BIOTECH S.L.
